Outcomes in idiopathic pulmonary fibrosis: A meta-analysis from placebo controlled trials

Respiratory Medicine

Volumn 108, Issue 2, 2014, Pages 376-387

  Atkins, C P ^a   Loke, Y K ^a,b   Wilson, A M ^a,b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Idiopathic pulmonary fibrosis; Lung diseases, interstitial; MeSH keywords; Meta analysis

Indexed keywords

BOSENTAN; COTRIMOXAZOLE; ETANERCEPT; EVEROLIMUS; GAMMA1B INTERFERON; IMATINIB; NINTEDANIB; PIRFENIDONE; PLACEBO; PREDNISOLONE; SILDENAFIL;

ARTICLE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RATE; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

IDIOPATHIC PULMONARY FIBROSIS; LUNG DISEASES, INTERSTITIAL; META-ANALYSIS;

AGED; DISEASE PROGRESSION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 84893726933     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.11.007     Document Type: Article

References (37)

1. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 7 2006 Oct 1 810 816
2. J.A. Bjoraker, J.H. Ryu, M.K. Edwin, J.L. Myers, H.D. Tazelaar, and D.R. Schroeder et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1 1998 Jan 1 199 203
3. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) Am J Respir Crit Care Med 161 2 Pt 1 2000 Feb 646 664
4. G. Raghu, H.R. Collard, J.J. Egan, F.J. Martinez, J. Behr, and K.K. Brown et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 6 2011 Mar 15 788 824
5. A.U. Wells, J. Behr, U. Costabel, V. Cottin, V. Poletti, and L. Richeldi Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good Thorax 67 11 2012 Nov 938 940
6. R. Hyzy, S. Huang, J. Myers, K. Flaherty, and F. Martinez Acute exacerbation of idiopathic pulmonary fibrosis Chest 132 5 2007 Nov 1652 1658
7. D.S. Kim, J.H. Park, B.K. Park, J.S. Lee, A.G. Nicholson, and T. Colby Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Eur Respir J 27 1 2006 Jan 143 150
8. L. Shulgina, A.P. Cahn, E.R. Chilvers, H. Parfrey, A.B. Clark, and E.C.F. Wilson et al. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial Thorax 68 2 2013 Feb 155 162
9. M. Demedts, J. Behr, R. Buhl, U. Costabel, R. Dekhuijzen, and H.M. Jansen et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 21 2005 Nov 24 2229 2242
10. P.W. Noble, C. Albera, W.Z. Bradford, U. Costabel, M.K. Glassberg, and D. Kardatzke et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 9779 2011 1760 1769
11. L. Richeldi, U. Costabel, M. Selman, D.S. Kim, D.M. Hansell, and A.G. Nicholson et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis N Engl J Med 365 12 2011 Sep 21 1079 1087
12. G. Raghu, K.J. Anstrom, T.E. King Jr., J.A. Lasky, and F.J. Martinez Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis N Engl J Med 366 21 2012 May 24 1968 1977
13. G. Raghu, H.R. Collard, K.J. Anstrom, K.R. Flaherty, T.R. Fleming, and T.E. King Jr. et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials Am J Respir Crit Care Med 185 10 2012 May 15 1044 1048
14. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, and D.J. Gavaghan et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1996 Feb 1 12
15. H. Kubo, K. Nakayama, M. Yanai, T. Suzuki, M. Yamaya, and M. Watanabe et al. Anticoagulant therapy for idiopathic pulmonary fibrosis Chest 128 3 2005 Sep 1475 1482
16. W.W. Douglas, J.H. Ryu, S.J. Swensen, K.P. Offord, D.R. Schroeder, and G.M. Caron et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group Am J Respir Crit Care Med 158 1 1998 Jul 220 225
17. R. Ziesche, E. Hofbauer, K. Wittmann, V. Petkov, and L.H. Block A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis N Engl J Med 341 17 1999 Oct 21 1264 1269
18. I. Noth, K.J. Anstrom, S.B. Calvert, J. De Andrade, K.R. Flaherty, and C. Glazer et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 186 1 2012 Jul 1 88 95
19. G. Raghu, W.J. Depaso, K. Cain, S.P. Hammar, C.E. Wetzel, and D.F. Dreis et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial Am Rev Respir Dis 144 2 1991 Aug 291 296
20. G. Raghu, K.K. Brown, W.Z. Bradford, K. Starko, P.W. Noble, and D.A. Schwartz et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis N Engl J Med 350 2 2004 Jan 8 125 133
21. T.E. King Jr., J. Behr, K.K. Brown, R.M. Du Bois, L. Lancaster, and J.A. De Andrade et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 177 1 2008 Jan 1 75 81
22. T.E. King Jr., K.K. Brown, G. Raghu, R.M. Du Bois, D.A. Lynch, and F. Martinez et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 1 2011 Jul 1 92 99
23. T.E. King Jr., C. Albera, W.Z. Bradford, U. Costabel, P. Hormel, and L. Lancaster et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial Lancet 374 9685 2009 Jul 18 222 228
24. C.E. Daniels, J.A. Lasky, A.H. Limper, K. Mieras, E. Gabor, and D.R. Schroeder Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo-controlled trial results Am J Respir Crit Care Med 181 6 2010 Mar 15 604 610
25. H. Taniguchi, M. Ebina, Y. Kondoh, T. Ogura, A. Azuma, and M. Suga et al. Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 4 2010 Apr 821 829
26. G. Raghu, K.K. Brown, U. Costabel, V. Cottin, R.M. Du Bois, and J.A. Lasky et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial Am J Respir Crit Care Med 178 9 2008 Nov 1 948 955
27. M.A. Malouf, P. Hopkins, G. Snell, and A.R. Glanville An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis Respirology 16 5 2011 Jul 776 783
28. A. Azuma, T. Nukiwa, E. Tsuboi, M. Suga, S. Abe, and K. Nakata et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 9 2005 May 1 1040 1047
29. D.A. Zisman, M. Schwarz, K.J. Anstrom, H.R. Collard, K.R. Flaherty, and G.W. Hunninghake A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis N Engl J Med 363 7 2010 Aug 12 620 628
30. F. Buttgereit, R.H. Straub, M. Wehling, and G.-R. Burmester Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action Arthritis Rheum 50 11 2004 3408 3417
31. H. Müllerova, C. Chigbo, G.W. Hagan, M.A. Woodhead, M. Miravitlles, and K.J. Davis et al. The natural history of community-acquired pneumonia in COPD patients: a population database analysis Respir Med 106 8 2012 Aug 1124 1133
32. T. Araki, H. Katsura, M. Sawabe, and K. Kida A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients Intern Med 42 6 2003 Jun 483 489
33. D. Savici, P.A. Campbell, and T.E. King Bronchoalveolar macrophages from patients with idiopathic pulmonary fibrosis are unable to kill facultative intracellular bacteria Am J Respir Crit Care Med 139 1 1989 Jan 1 22 27
34. Y. Sibille, and H.Y. Reynolds Macrophages and polymorphonuclear neutrophils in lung defense and injury Am Rev Respir Dis 141 2 1990 Feb 471 501
35. J. Gribbin, R.B. Hubbard, I. Le Jeune, C.J.P. Smith, J. West, and L.J. Tata Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax 61 11 2006 Nov 980 985
36. W.G. Melsen, M.M. Rovers, M. Koeman, and M.J.M. Bonten Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies Crit Care Med 39 12 2011 Dec 2736 2742
37. W.G. Melsen, M.M. Rovers, R.H.H. Groenwold, D.C.J.J. Bergmans, C. Camus, and T.T. Bauer et al. Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies Lancet Infect Dis 13 8 2013 Aug 665 671